{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:06:06Z","timestamp":1716595566015},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"vor","delay-in-days":773,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/s1413-8670(11)70202-1","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T11:15:18Z","timestamp":1351854918000},"page":"339-348","source":"Crossref","is-referenced-by-count":7,"title":["Antimicrobial activity of ceftobiprole against Gram-negative and Gram-positive pathogens: results from INVITA-A-CEFTO Brazilian study"],"prefix":"10.1016","volume":"15","author":[{"given":"Ros\u00e2ngela Ferraz","family":"Cereda","sequence":"first","affiliation":[]},{"given":"Heber Dias","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Girardello","sequence":"additional","affiliation":[]},{"given":"Danilo Elias","family":"Xavier","sequence":"additional","affiliation":[]},{"given":"Ana C.","family":"Gales","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/S1413-8670(11)70202-1_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14787210.6.6.805","article-title":"Cefepime: a reappraisal in an era of increasing antimicrobial resistance","volume":"6","author":"Endimiani","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"5","key":"10.1016\/S1413-8670(11)70202-1_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","article-title":"Efficacy and safety of cefepime: a systematic review and meta-analysis","volume":"7","author":"Yahav","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/S1413-8670(11)70202-1_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1590\/S1413-86702009000200004","article-title":"Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005\u20132008)","volume":"13","author":"Gales","year":"2009","journal-title":"Braz J Infect Dis"},{"issue":"Suppl2","key":"10.1016\/S1413-8670(11)70202-1_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2007.01725.x","article-title":"Clinical profile of ceftobiprole, a novel beta-lactam antibiotic","volume":"13","author":"Noel","year":"2007","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/S1413-8670(11)70202-1_bib5","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1128\/AAC.00029-07","article-title":"Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Staphylococcus aureus, and Streptococcus pneumoniae","volume":"51","author":"Davies","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/S1413-8670(11)70202-1_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.diagmicrobio.2008.02.008","article-title":"Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005\u20132006)","volume":"61","author":"Fritsche","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/S1413-8670(11)70202-1_bib7","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","article-title":"Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin","volume":"49","author":"Bogdanovich","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/S1413-8670(11)70202-1_bib8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.00044-06","article-title":"Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis","volume":"50","author":"Bogdanovich","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/S1413-8670(11)70202-1_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/S1413-8670(11)70202-1_bib10","series-title":"M7-A8 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","year":"2009"},{"key":"10.1016\/S1413-8670(11)70202-1_bib11","series-title":"Performance standards for antimicrobial susceptibility testing: 21st informational supplement","year":"2011"},{"key":"10.1016\/S1413-8670(11)70202-1_bib12","unstructured":"Doribax[package insert]. Raritan, NJ: Ortho-McNeil Pharmaceutical, Inc, 2007."},{"key":"10.1016\/S1413-8670(11)70202-1_bib13","unstructured":"Tygacil [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc, 2005"},{"issue":"1","key":"10.1016\/S1413-8670(11)70202-1_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jac\/dkq397","article-title":"Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study","volume":"66","author":"Rossolini","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/S1413-8670(11)70202-1_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/jac\/dkp176","article-title":"Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model","volume":"64","author":"Zhanel","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/S1413-8670(11)70202-1_bib16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/S1413-8670(11)70202-1_bib17","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/AAC.00218-07","article-title":"Interactions of ceftobiprole with beta-lactamases from molecular classes A to D","volume":"51","author":"Queenan","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/S1413-8670(11)70202-1_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jac\/dkg416","article-title":"Dissemination in distinct Brazilian regions of an epidemic carbapenemresistant producing SPM metallo-beta-lactamase","volume":"52","author":"Gales","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/S1413-8670(11)70202-1_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajic.2009.09.012","article-title":"Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil","volume":"38","author":"Schimith Bier","year":"2010","journal-title":"Am J Infect Control"},{"issue":"Suppl 2","key":"10.1016\/S1413-8670(11)70202-1_bib20","first-page":"3","article-title":"Antimicrobial susceptibility patterns of Gram-negative bacilli isolated in Brazilian hospitals participating in the SENTRY Program (2003\u20132008)","volume":"12","author":"Andrade","year":"2008","journal-title":"Braz J Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867011702021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867011702021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T16:20:39Z","timestamp":1540138839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867011702021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1413867011702021"],"URL":"https:\/\/doi.org\/10.1016\/s1413-8670(11)70202-1","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}